October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
ESTRO – To Escalate or to De-Escalate Radiation Dose in Stage 3 NSCLC?
Jul 25, 2024, 23:48

ESTRO – To Escalate or to De-Escalate Radiation Dose in Stage 3 NSCLC?

European Society for Radiotherapy and Oncology shared on LinkedIn:

“Key insights from ESTRO24 on the optimisation of radiation doses for stage III NSCLC in the era of immunotherapy and tyrosine kinase inhibitors. Learn about dose escalation trials, individualised treatment strategies, and the role of biomarkers in the guidance of therapy.”

Read further.
Source: European Society for Radiotherapy and Oncology/LinkedIn